Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2025-12-29 @ 4:45 PM
Study NCT ID:
NCT07215806
Status:
COMPLETED
Last Update Posted:
2025-11-14
First Post:
2025-10-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive
Sponsor:
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-25
Completion Date Type:
ACTUAL
First Submit Date:
2025-10-08
First Submit QC Date:
None
Study First Post Date:
2025-10-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-10-29
Results First Submit QC Date:
None
Results First Post Date:
2025-11-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-29
Last Update Post Date:
2025-11-14
Last Update Post Date Type:
ESTIMATED